Company: PGEN
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001356090-25-000019
Chunk: 16

Company: PRECIGEN, INC.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 1
Chunk 16
---
SharesAmountBalances at December 31, 2023— $— 248,919,096 $— 7,479,431 $— $2,084,916 $(1,947)$(1,964,471)$118,498 Stock-based compensation expense— — — — — — 2,581 — — 2,581 Shares issued upon vesting of restricted stock units and for exercises of stock options— — 961,534 — (961,534)— — — — — Shares issued as payment for services— — 368,178 — (368,178)— 528 — — 528 Net loss— — — — — — — — (23,738)(23,738)Other comprehensive loss— — — — — — — (850)— (850)Balances at March 31, 2024— $— 250,248,808 $— 6,149,719 $— $2,088,025 $(2,797)$(1,988,209)$97,019 

The accompanying notes are an integral part of these condensed consolidated financial statements.

8

Precigen, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 Three Months Ended  March 31,(Amounts in thousands)20252024Cash flows from operating activitiesNet loss$(54,153)$(23,738)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization629 1,595 Gain on disposals of assets, net— (3)Change in fair value of warrant liabilities32,481 — Amortization of discounts on investments, net(706)(397)Stock-based compensation expense2,677 2,581 Shares issued as payment for services527 528 Deferred income taxes— (29)Changes in operating assets and liabilities:Receivables:Trade175 30 Other(76)383 Prepaid expenses46 699 Other assets(56)4 Accounts payable(117)2,653 Accrued compensation and benefits1,204 1,722 Other accrued liabilities1,277 (126)Deferred revenue(138)(32)